Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs VISTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA VISTA PHARMA SAMRAT PHARMA/
VISTA PHARMA
 
P/E (TTM) x 4,683.0 -6.0 - View Chart
P/BV x 1.6 1.7 98.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 SAMRAT PHARMA   VISTA PHARMA
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
VISTA PHARMA
Mar-23
SAMRAT PHARMA/
VISTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,25014 8,674.5%   
Low Rs3327 5,099.8%   
Sales per share (Unadj.) Rs1,005.30.3 376,096.4%  
Earnings per share (Unadj.) Rs53.8-1.5 -3,570.4%  
Cash flow per share (Unadj.) Rs55.9-1.3 -4,162.8%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs204.38.1 2,512.4%  
Shares outstanding (eoy) m3.0937.56 8.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.839.1 2.0%   
Avg P/E ratio x14.7-6.9 -211.8%  
P/CF ratio (eoy) x14.1-7.8 -181.7%  
Price / Book Value ratio x3.91.3 301.0%  
Dividend payout %1.90-   
Avg Mkt Cap Rs m2,444393 622.1%   
No. of employees `000NANA-   
Total wages/salary Rs m115 210.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,10610 30,940.8%  
Other income Rs m54 119.8%   
Total revenues Rs m3,11114 22,175.6%   
Gross profit Rs m239-44 -538.3%  
Depreciation Rs m66 104.0%   
Interest Rs m1212 101.5%   
Profit before tax Rs m225-59 -383.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m59-2 -2,757.0%   
Profit after tax Rs m166-57 -293.7%  
Gross profit margin %7.7-442.7 -1.7%  
Effective tax rate %26.23.6 718.0%   
Net profit margin %5.4-563.9 -0.9%  
BALANCE SHEET DATA
Current assets Rs m986238 415.2%   
Current liabilities Rs m528141 374.6%   
Net working cap to sales %14.8963.0 1.5%  
Current ratio x1.91.7 110.8%  
Inventory Days Days8207 3.9%  
Debtors Days Days60240,902 1.5%  
Net fixed assets Rs m175296 59.2%   
Share capital Rs m3175 41.1%   
"Free" reserves Rs m601230 260.7%   
Net worth Rs m631306 206.7%   
Long term debt Rs m052 0.0%   
Total assets Rs m1,162534 217.6%  
Interest coverage x19.3-3.8 -502.1%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x2.70 14,221.2%   
Return on assets %15.4-8.3 -184.6%  
Return on equity %26.3-18.5 -142.1%  
Return on capital %37.6-13.1 -288.4%  
Exports to sales %4.10-   
Imports to sales %83.30-   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,587NA-   
Fx inflow Rs m1270-   
Fx outflow Rs m2,5870-   
Net fx Rs m-2,4600-   
CASH FLOW
From Operations Rs m-94-17 551.5%  
From Investments Rs m-30-13 236.6%  
From Financial Activity Rs m9631 308.3%  
Net Cashflow Rs m-281 -2,153.8%  

Share Holding

Indian Promoters % 48.6 15.6 311.2%  
Foreign collaborators % 0.0 12.2 -  
Indian inst/Mut Fund % 3.2 0.0 10,800.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 72.2 71.1%  
Shareholders   8,065 13,908 58.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs VISTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs VISTA PHARMA Share Price Performance

Period SAMRAT PHARMA VISTA PHARMA S&P BSE HEALTHCARE
1-Day -1.87% -2.83% 1.18%
1-Month -10.12% -22.19% -0.75%
1-Year -2.44% 28.28% 61.82%
3-Year CAGR 34.42% 4.50% 18.16%
5-Year CAGR 38.09% -11.60% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the VISTA PHARMA share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of VISTA PHARMA the stake stands at 27.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of VISTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

VISTA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of VISTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.